Literature DB >> 18424523

Mutations in the tacF gene of clinical strains and laboratory transformants of Streptococcus pneumoniae: impact on choline auxotrophy and growth rate.

Ana González1, Daniel Llull, María Morales, Pedro García, Ernesto García.   

Abstract

The nutritional requirement that Streptococcus pneumoniae has for the aminoalcohol choline as a component of teichoic and lipoteichoic acids appears to be exclusive to this prokaryote. A mutation in the tacF gene, which putatively encodes an integral membrane protein (possibly, a teichoic acid repeat unit transporter), has been recently identified as responsible for generating a choline-independent phenotype of S. pneumoniae (M. Damjanovic, A. S. Kharat, A. Eberhardt, A. Tomasz, and W. Vollmer, J. Bacteriol. 189:7105-7111, 2007). We now report that Streptococcus mitis can grow in choline-free medium, as previously illustrated for Streptococcus oralis. While we confirmed the finding by Damjanovic et al. of the involvement of TacF in the choline dependence of the pneumococcus, the genetic transformation of S. pneumoniae R6 by using S. mitis SK598 DNA and several PCR-amplified tacF fragments suggested that a minimum of two mutations were required to confer improved fitness to choline-independent S. pneumoniae mutants. This conclusion is supported by sequencing results also reported here that indicate that a spontaneous mutant of S. pneumoniae (strain JY2190) able to proliferate in the absence of choline (or analogs) is also a double mutant for the tacF gene. Microscopic observations and competition experiments during the cocultivation of choline-independent strains confirmed that a minimum of two amino acid changes were required to confer improved fitness to choline-independent pneumococcal strains when growing in medium lacking any aminoalcohol. Our results suggest complex relationships among the different regions of the TacF teichoic acid repeat unit transporter.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18424523      PMCID: PMC2446756          DOI: 10.1128/JB.01991-07

Source DB:  PubMed          Journal:  J Bacteriol        ISSN: 0021-9193            Impact factor:   3.490


  38 in total

1.  Nutritional Requirements of the Pneumococcus: I. Growth Factors for Types I, II, V, VII, VIII.

Authors:  L Rane; Y Subbarow
Journal:  J Bacteriol       Date:  1940-11       Impact factor: 3.490

2.  Simple genetic method to identify viridans group streptococci by colorimetric dot hybridization and fluorometric hybridization in microdilution wells.

Authors:  T Ezaki; Y Hashimoto; N Takeuchi; H Yamamoto; S L Liu; H Miura; K Matsui; E Yabuuchi
Journal:  J Clin Microbiol       Date:  1988-09       Impact factor: 5.948

3.  Cellular metabolism in genetic transformation of pneumococci: requirement for protein synthesis during induction of competence.

Authors:  A Tomasz
Journal:  J Bacteriol       Date:  1970-03       Impact factor: 3.490

4.  Complete genome sequence of a virulent isolate of Streptococcus pneumoniae.

Authors:  H Tettelin; K E Nelson; I T Paulsen; J A Eisen; T D Read; S Peterson; J Heidelberg; R T DeBoy; D H Haft; R J Dodson; A S Durkin; M Gwinn; J F Kolonay; W C Nelson; J D Peterson; L A Umayam; O White; S L Salzberg; M R Lewis; D Radune; E Holtzapple; H Khouri; A M Wolf; T R Utterback; C L Hansen; L A McDonald; T V Feldblyum; S Angiuoli; T Dickinson; E K Hickey; I E Holt; B J Loftus; F Yang; H O Smith; J C Venter; B A Dougherty; D A Morrison; S K Hollingshead; C M Fraser
Journal:  Science       Date:  2001-07-20       Impact factor: 47.728

5.  Autolysis and cell wall degradation in a choline-independent strain of Streptococcus pneumoniae.

Authors:  A Severin; D Horne; A Tomasz
Journal:  Microb Drug Resist       Date:  1997       Impact factor: 3.431

6.  Incorporation of choline into Streptococcus pneumoniae cell wall antigens: evidence for choline kinase activity.

Authors:  G C Whiting; S H Gillespie
Journal:  FEMS Microbiol Lett       Date:  1996-05-01       Impact factor: 2.742

7.  The pneumococcal common antigen C-polysaccharide occurs in different forms. Mono-substituted or di-substituted with phosphocholine.

Authors:  C Karlsson; P E Jansson; U B Skov Sørensen
Journal:  Eur J Biochem       Date:  1999-11

8.  Molecular basis of the optochin-sensitive phenotype of pneumococcus: characterization of the genes encoding the F0 complex of the Streptococcus pneumoniae and Streptococcus oralis H(+)-ATPases.

Authors:  A Fenoll; R Muñoz; E García; A G de la Campa
Journal:  Mol Microbiol       Date:  1994-05       Impact factor: 3.501

9.  Essential role of choline for pneumococcal virulence in an experimental model of meningitis.

Authors:  F Gehre; S L Leib; D Grandgirard; J Kummer; A Bühlmann; F Simon; R Gäumann; A S Kharat; M G Täuber; A Tomasz
Journal:  J Intern Med       Date:  2008-03-05       Impact factor: 8.989

10.  The essential tacF gene is responsible for the choline-dependent growth phenotype of Streptococcus pneumoniae.

Authors:  Marlen Damjanovic; Arun S Kharat; Alice Eberhardt; Alexander Tomasz; Waldemar Vollmer
Journal:  J Bacteriol       Date:  2007-07-27       Impact factor: 3.490

View more
  3 in total

1.  ClyJ Is a Novel Pneumococcal Chimeric Lysin with a Cysteine- and Histidine-Dependent Amidohydrolase/Peptidase Catalytic Domain.

Authors:  Hang Yang; Yujing Gong; Huaidong Zhang; Irina Etobayeva; Paulina Miernikiewicz; Dehua Luo; Xiaohong Li; Xiaoxu Zhang; Krystyna Dąbrowska; Daniel C Nelson; Jin He; Hongping Wei
Journal:  Antimicrob Agents Chemother       Date:  2019-03-27       Impact factor: 5.191

2.  A Choline-Recognizing Monomeric Lysin, ClyJ-3m, Shows Elevated Activity against Streptococcus pneumoniae.

Authors:  Dehua Luo; Li Huang; Vijay Singh Gondil; Wanli Zhou; Wan Yang; Minghui Jia; Shencai Hu; Jin He; Hang Yang; Hongping Wei
Journal:  Antimicrob Agents Chemother       Date:  2020-11-17       Impact factor: 5.191

3.  Fluorescence Imaging of Streptococcus pneumoniae with the Helix pomatia agglutinin (HPA) As a Potential, Rapid Diagnostic Tool.

Authors:  Mirian Domenech; Ernesto García
Journal:  Front Microbiol       Date:  2017-07-18       Impact factor: 5.640

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.